RARA and acute promyelocytic leukemia: Therapeutic function of ATRA in APL includes activating the gene transcription in myeloid lineage differentiation and degrading the PML–RARα oncoprotein, while arsenictrioxide (ATO) degrades all PML containing molecules and promotes apoptosis.